CMV INFECTION
Clinical trials for CMV INFECTION explained in plain language.
Never miss a new study
Get alerted when new CMV INFECTION trials appear
Sign up with your email to follow new studies for CMV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New scoring system could cut Post-Transplant virus infections
Disease control Not yet recruitingThis study aims to reduce CMV infections in stem cell transplant patients by using a scoring system that measures immune recovery. The system helps doctors decide when to stop antiviral medication (letermovir) safely. Over 1,100 participants will be enrolled to see if this approa…
Matched conditions: CMV INFECTION
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 10:17 UTC
-
Transplant patients may get smarter CMV care
Disease control Not yet recruitingThis study looks at whether adjusting the dose of anti-rejection drugs can help control CMV infection in organ transplant recipients. About 100 adults who have had a kidney, liver, heart, lung, or pancreas transplant and now have CMV will take part. The goal is to see if this app…
Matched conditions: CMV INFECTION
Phase: PHASE4 • Sponsor: Oriol Manuel • Aim: Disease control
Last updated May 26, 2026 10:14 UTC
-
New hope for CMV eye infection: antiviral showdown begins
Disease control Not yet recruitingThis study compares two antiviral treatments—oral valganciclovir and ganciclovir eye drops—against a placebo for cytomegalovirus (CMV) anterior uveitis, a viral infection that causes inflammation inside the front of the eye. About 117 adults with active eye inflammation will rece…
Matched conditions: CMV INFECTION
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 26, 2026 10:07 UTC
-
New drug may offer easier protection against virus for kidney transplant patients
Prevention Not yet recruitingThis study compares two medications, letermovir and valganciclovir, to see which better prevents CMV infection in 300 kidney transplant recipients who carry the virus. Participants take the drug for 90 days after transplant, and researchers track infections for 12 months. The goa…
Matched conditions: CMV INFECTION
Phase: PHASE4 • Sponsor: Elisabeth Kincaide • Aim: Prevention
Last updated May 19, 2026 11:47 UTC